Immutep Ltd

Immutep Insider Deals Spark Buzz: CEO Stakes $0.08 Share, 1M‑Share Performance Rights Signal Possible Turnaround 2026 Flash

Insider buys reveal Immutep’s confidence: executive stake and 1 m performance‑right shares hint at a possible biotech turnaround.

Immutep Ltd
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

16/04/2026, 12:23

3 minutes to read

Immutep Insider Holds Steady: Owner’s 4M Shares Stay Put Amidst Volatile Valuation and 2026 Trial Stakes

Insider activity shows Immutep’s CEO holds steady stake while receiving performance‑right grants tied to upcoming trials, indicating long‑term upside despite low price.

Immutep Ltd
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

08/04/2026, 18:42

2 minutes to read